Status:
COMPLETED
Accuracy of Lung Injury Biomarkers in the Initial Investigation of Patients With Suspected Pneumonia
Lead Sponsor:
University of Southern Denmark
Conditions:
Community-acquired Pneumonia
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to investigate the diagnostic and prognostic value of surfactant protein D, Krebs von den Lungen (KL-6), and Chitinase-3-like protein 1 (YKL-40) in the initial investigation o...
Detailed Description
Community-acquired pneumonia (CAP) is one of the most common infection diseases in the emergency department (ED). Diagnosis of pneumonia is challenging as symptoms are often weak and nonspecific and t...
Eligibility Criteria
Inclusion
- Suspicion of APN assessed by the receiving physician at the ED
Exclusion
- If the attending physician considers that participation will delay a life-saving treatment or patient needs direct transfer to the intensive care unit.
- Admission within the last 14 days
- Verified COVID-19 disease within 14 days before admission
- Pregnant women
- Severe immunodeficiencies: Primary immunodeficiencies and secondary immunodeficiencies (HIV positive CD4 \<200, Patients receiving immunosuppressive treatment (ATC L04A), Corticosteroid treatment (\>20 mg/day prednisone or equivalent for \>14 days within the last 30 days), Chemotherapy within 30 days)
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2022
Estimated Enrollment :
411 Patients enrolled
Trial Details
Trial ID
NCT04686331
Start Date
March 1 2021
End Date
June 1 2022
Last Update
September 14 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital of Southern Jutland
Aabenraa, Denmark